Structure via PubChem · Public domain (PubChem)
anakinra
Sign in to saveAlso known as Antril, IL-1RN, ICIL-1RA, IL1 inhibitor, IRAP, IL-1ra, interleukin-1 receptor antagonist protein precursor
Anakinra, sold under the brand name Kineret, is a biopharmaceutical medication used to treat rheumatoid arthritis, cryopyrin-associated periodic syndromes, familial Mediterranean fever, and Still's disease. It is a slightly modified recombinant version of the human interleukin 1 receptor antagonist protein. It is marketed by Swedish Orphan Biovitrum. Anakinra is administered by subcutaneous injection.
Chemical data
- Formula
- C20H23N5O7S2
- Molecular weight
- 509.6 g/mol
- IUPAC name
- (7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(2,2-dimethylpropanoyloxymethoxyimino)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- SMILES
- CC(C)(C)C(=O)OCO/N=C(/C1=CSC(=N1)N)\C(=O)N[C@H]2C3N(C2=O)C(=C(CS3)C=C)C(=O)O
- InChIKey
- HMLGSIZOMSVISS-ONJSNURVSA-N
- XLogP
- 1.1
- Polar surface area
- 227 Ų
- H-bond donors
- 3
- H-bond acceptors
- 12
- Formal charge
- 0
via PubChem
Wikidata facts
- Mass
- 509.103890076
Show 5 more facts
- defined daily dose
- 0.1
- NCI Thesaurus ID
- C38717
- chemical formula
- C₂₀H₂₃N₅O₇S₂
- isomeric SMILES
- C=CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)/C(=N\OCOC(=O)C(C)(C)C)c3csc(=N)[nH]3)C2SC1
- canonical SMILES
- C=CC1=C(C(=O)O)N2C(=O)C(NC(=O)C(=NOCOC(=O)C(C)(C)C)c3csc(=N)[nH]3)C2SC1
Sources (6)
via Wikidata · CC0
~8 min read
Article
10 sectionsContents
- Medical uses
- Safety
- Adverse reactions
- Chemistry
- History
- Society and culture
- Legal status
- Research
- COVID-19
- References
Anakinra, sold under the brand name Kineret, is a biopharmaceutical medication used to treat rheumatoid arthritis, cryopyrin-associated periodic syndromes, familial Mediterranean fever, and Still's disease. It is a slightly modified recombinant version of the human interleukin 1 receptor antagonist protein. It is marketed by Swedish Orphan Biovitrum. Anakinra is administered by subcutaneous injection.
==Medical uses== It is used as a second line treatment to manage symptoms of rheumatoid arthritis after treatment with a disease-modifying antirheumatic drug (DMARD) has failed. It can be used in combination with some DMARDs.